Masters of Longevity - The Pulse

Longevity Technology18 Jun 2026
AIQihan Biotech cell therapy makes history with three expedited FDA designations (Longevity Technology)

Qihan Biotech cell therapy makes history with three expedited FDA designations

Examine an off-the-shelf dual-target allogeneic CAR-T therapy securing top expedited regulatory pathways and implications for off-the-shelf cell therapy development.

Key takeaways
  • Awards follow a Fast Track designation granted in November 2025.
  • We are open to conversations with prospective partners and investors who share our vision.
  • Hangzhou Qihan Biotech announced that its off-the-shelf.
Frontiers - Health18 Jun 2026
AIThe levels of vascular endothelial cells and endothelium-dependent vasomotor cytokines in children with essential hypertension: a case-control study (Frontiers

The levels of vascular endothelial cells and endothelium-dependent vasomotor cytokines in children with essential hypertension: a case-control study

Examination of endothelial cell markers and vasomotor cytokines in pediatric essential hypertension to map early vascular dysfunction and biomarkers.

Key takeaways
  • However, these alterations have not been documented in childhood essential hypertension.
  • In recent years, the prevalence of pediatric essential hypertension has been on the rise.
  • Previous studies have shown that in adults hypertension.
Longevity Technology18 Jun 2026
AIEverlab raises AU$65 million to take preventative AI care global (Longevity Technology)

Everlab raises AU$65 million to take preventative AI care global

Digital preventative-care startup using AI for continuous patient support — this article explores its growth strategy and ambitious global rollout plans.

Key takeaways
  • Company closed an AU$65 million oversubscribed Series A led by Airtree Ventures.
  • Its platform processes over 200,000 monthly health reports and 21 million biomarker results.
  • Funding will support clinical and technology infrastructure and a UK-led global rollout.
Frontiers - Health18 Jun 2026
Glyphosate: North America (Frontiers - Health)

Glyphosate: North America

Assessing evidence that widespread herbicide use may drive chronic health and ecological harms and affect vulnerable communities.

Key takeaways
  • We examine how safety assumptions have been challenged by reassessment of early toxicological data.
  • Reframing glyphosate within this broader context is essential to inform policy.
  • As DDT's era ended, glyphosate-based herbicides (GBHs) quietly emerged onto the agricultural stage.